Video | 08 November 2023 Access to insulin pens - Ali DIABETES MSF has transitioned all patients with type 1 diabetes in our clinics in Lebanon from vials to insulin pens. Here are the stories from patients and staff about how the move has improved both medical outcomes and patients’ quality of life. Read, watch, share Filter by - Any -BlogEventsFeature storyIssue briefLetterPress releaseResearch articleTechnical briefVideo Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Amina 6 min Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Ghassan Fakhri Jabar 7 min Feature story Feature story | 01 November 2024 Diabetes Greece Migrating while managing diabetes: why access to insulin in pens must be available to everyone 2 min Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min Photo credit: Carmen Yahchouchi/MSF Press release Press release | 23 September 2024 Diabetes Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min Video Video | 15 May 2024 Diabetes Webinar: Part 2 - Access to GLP-1s (medicines like Ozempic) and SGLT-2s for people living with type 2 diabetes 1 min Video Video | 14 May 2024 Diabetes Webinar: Part 1 - Lowering the price of insulin everywhere: let’s make it a reality 1 min Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min Load More
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Amina 6 min
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Ghassan Fakhri Jabar 7 min
Feature story Feature story | 01 November 2024 Diabetes Greece Migrating while managing diabetes: why access to insulin in pens must be available to everyone 2 min
Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 23 September 2024 Diabetes Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min
Video Video | 15 May 2024 Diabetes Webinar: Part 2 - Access to GLP-1s (medicines like Ozempic) and SGLT-2s for people living with type 2 diabetes 1 min
Video Video | 14 May 2024 Diabetes Webinar: Part 1 - Lowering the price of insulin everywhere: let’s make it a reality 1 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min
